1 results match your criteria: "and ANZAC Institute University of Sydney[Affiliation]"
Balancing the Risks of Recurrent Ischaemic and Bleeding Events in a Stable Post ACS Population.
Heart Lung Circ
October 2022
Concord Hospital, and ANZAC Institute University of Sydney, Sydney, NSW, Australia.
Objective: To better guide decisions regarding antithrombotic treatment in individual patients surviving 6 months following an acute coronary syndrome (ACS) by balancing between subsequent recurrent ischaemic and bleeding risk.
Methods: Patients surviving 6 months following an ACS were followed in an Australian registry. Ischaemic (composite of cardiovascular death, myocardial infarction or stroke) and bleeding (≥BARC 2) events were collected.